Strategic Partnerships MO SCI’s history of collaboration with Fortune 500 companies and partnerships with regional innovation programs (Missouri S&T ecosystem, Critical Minerals and Materials Hub) indicate strong potential for co-development deals, contract manufacturing, and long-term supply agreements with large aerospace, healthcare, and industrial players.

Healthcare Applications With internationally recognized healthcare applications and a track record in bioceramics awards, MO SCI is well positioned to pursue opportunities in medical devices, wound care, implants, and specialty glass components used in diagnostics and therapy.

Specialty Glass Capabilities Their core strength in precision glass technology, microspheres, fibers, and frit can be leveraged to upsell into sectors requiring high-purity, custom glass materials for optics, sensors, and specialty lighting, targeting medtech, defense, and industrial electronics.

Acquisition & Growth Signals Past acquisition by Heraeus and continued selective collaborations suggest opportunities for channel partnerships, distribution deals, or minority investment conversations with global specialty materials groups seeking expanded glass capabilities.

Smaller Company Agility With a lean employee base and a revenue range of one to ten million, MO SCI can be a nimble candidate for pilot programs, OEM supplier arrangements, and rapid prototyping contracts with faster time-to-market compared to larger incumbents.